De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial.
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Background In patients with severe sepsis, no randomized clinical trial has tested the concept of de-escalation of empirical antimicrobial therapy. This study aimed to compare the de-escalation strategy with the continuation of an appropriate empirical treatment in those patients. Methods This was a multicenter non-blinded randomized noninferiority trial of patients with severe sepsis who were randomly assigned to de-escalation or continuation of empirical antimicrobial treatment. Recruitment began in February 2012 and ended in April 2013 in nine intensive care units (ICUs) in France. Patients with severe sepsis were assigned to de-escalation (n = 59) or continuation of empirical antimicrobial treatment (n = 57). The primary outcome was to measure the duration of ICU stay. We defined a noninferiority margin of 2 days. If the lower boundary of the 95 % confidence interval (CI) for the difference in patients assigned to the de-escalation group was less than 2 days, as compared with that of patients assigned to the continuation group, de-escalation was considered to be noninferior to the continuation strategy. Secondary outcomes included mortality at 90 days, occurrence of organ failure, number of superinfections, and number of days with antibiotics during the ICU stay. Results The median duration of ICU stay was 9 [interquartile range (IQR) 5-22] days in the de-escalation group and 8 [IQR 4-15] days in the continuation group, respectively (P = 0.71). The mean difference was 3.4…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified direct evidence from 13 studies (1968 patients) [277], including 1 RCT [278]. In our meta-analysis, we observed improved short-term mortality in patients who were de-escalated (RR 0.72; 95% CI 0.57–0.91) (Supplementary Appendix 2).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [278]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
Hooton, T. M., Bradley, S. F., Cardenas, D. D., Colgan, R., Geerlings, S. E., Rice, J. C., Saint, S., Schaeffer, A. J., Tambayh, P. A., Tenke, P., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650482 · Cited by 2,099 · cited 10×
“The choice of antibiotics was based on international guidelines [3, 15–18].”
BackgroundMethodInfluentialIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 9×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluentialPractice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602 · cited 10×
“The choice of antibiotics was based on international guidelines [3, 15–18].”
BackgroundMethodInfluentialSolomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Cited by
Items 101–200 of 241
Wu, X., Wu, J., Wang, P., Fang, X., Yu, Y., Tang, J., Xiao, Y., Wang, M., Li, S., Zhang, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1513 · Cited by 25
Effective implementation of the Accelerate Pheno™ system for positive blood cultures
Humphries, R. M., & Martino, T. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky534 · Cited by 21
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Bacterial sepsis: Diagnostics and calculated antibiotic therapy
Richter, D., Heininger, A., Brenner, T., Hochreiter, M., Bernhard, M., Briegel, J., Dubler, S., Grabein, B., Hecker, A., Krüger, W. A., et al. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0396-z · Cited by 22
“[146] showed in their study published in 2014, e.”
ResultMartín‐Loeches, I., Léone, M., Madách, K., Martin, C., & Einav, S. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000595 · Cited by 17
Self-citationAntibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
Singer, S., Kolodziej, L. E., Micek, S. T., & Kollef, M. H. (2025) · Antibiotics · doi:10.3390/antibiotics14050467 · Cited by 21
The role of antimicrobial therapy stewardship in intensive care service
Руднов, В. А., Колотова, Г. Б., Bagin, V. A., Nevskaya, N. N., Belsky, D. V., Ivanova, N. A., & Гайфутдинов, Е. А. (2018) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2018.2.132-140 · Cited by 16
The Evolving Role of Antimicrobial Stewardship in Management of Multidrug Resistant Infections
Goff, D. A., & File, T. M. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.012 · Cited by 16
Garnier, M., Rozencwajg, S., Pham, T. O., Vimont, S., Blayau, C., Hafiani, M., Fulgencio, J.-P., Bonnet, F. J., Mainardi, J., Arlet, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1746-6 · Cited by 15
“However, this conventional AST-guided de-escalation occurs 48 to 72 hours after initiation of EAT [8].”
Léone, M., Roberts, J. A., Bassetti, M., Bouglé, A., Lavigne, J.-P., Legrand, M. M., Neely, M. N., Paiva, J.-A., Payen, D. M., Rello, J., et al. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.09.009 · Cited by 17
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae
Carrara, E., Conti, M., Meschiari, M., & Mussini, C. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa493 · Cited by 15
A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection
Fierens, J., Depuydt, P. O., & Waele, J. J. D. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693995 · Cited by 17
Antibiotic De-escalation in adults hospitalized for community-onset Sepsis
Gupta, A. B., Heath, M., Walzl, E., Ratz, D., Munroe, E., Vaughn, V. M., Horowitz, J. K., Czilok, T., Petty, L. A., Gandhi, T. N., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.6919 · Cited by 14
Hughes, J. S., Huo, X., Falk, L., Hurford, A., Lan, K., Coburn, B. A., Morris, A. M., & Wu, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171218 · Cited by 15
Less empiric broad-spectrum antibiotics is more in the ICU
Ribeiro, J. M. D. F. P., & Park, M. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05863-z · Cited by 15
Guidelines for Antibiotics Prescription in Critically Ill Patients
Chaudhry, D., Desai, M., Gupta, M., Mohan, A., Mehta, Y. B., Sengar, M., Govil, D., Hegde, A. V., Rungta, N., Mittal, S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24677 · Cited by 20
van Heijl, I., Schweitzer, V. A., Boel, C. H. E., Oosterheert, J. J., Huijts, S. M., Dorigo‐Zetsma, W., van der Linden, P. D., Bonten, M. J. M., & van Werkhoven, C. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218062 · Cited by 13
“Although not statistically significant, this trend may indicate potential harm rather than improved outcome due to de-escalation [4].”
BackgroundAvdeev, S. N., Belotserkovskiy, B. Z., Dekhnich, A. V., Zaytsev, A. A., Kozlov, R. S., Николаевич, П. Д., RATCHINA, S. A., Sinopalnikov, A. I., Yakovlev, S. V., & Yaroshetskiy, A. I. (2021) · Annals of critical care · doi:10.21320/1818-474x-2021-3-27-46 · Cited by 16
“В исследованиях пациентов ОРИТ с тяжелыми ин-фекциями деэскалация являлась эффективной и безо-пасной стратегией, использование которой сопрово-ждалось сокращением длительности госпитализации, продолжительности АБТ и частоты АБ-ассоциирован-ных осложнений [98, 99].”
Impact of de-escalation on ICU patients’ prognosis
Waele, J. J. D., Bassetti, M., & Martín‐Loeches, I. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3488-0 · Cited by 14
“[8] casts significant doubt whether the reduction of the spectrum of the antibiotic can be considered safe as a routine measure.”
BackgroundResultOptimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
Arain, S. I., Khalawi, F., Parakkal, S. A., AlHamad, H. S., Thorakkattil, S. A., Alghashmari, F. F. J., Alharbi, B. A., Bakhashwain, N., Alzawad, W. M., & Al‐Homoud, A. H. (2023) · Antibiotics · doi:10.3390/antibiotics12071192 · Cited by 13
Garnier, M., Gallah, S., Vimont, S., Benzerara, Y., Labbé, V., Constant, A.-L., Siami, S., Guérot, E., Compain, F., Mainardi, J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024561 · Cited by 11
van Heijl, I., Schweitzer, V. A., van der Linden, P. D., Bonten, M. J. M., & van Werkhoven, C. H. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1743683 · Cited by 12
“The current evidence base on the safety of de-escalation of empirical antimicrobial therapy contains one RCT and 52 observational studies that suffer from various methodological limitations.”
BackgroundInfluentialBattula, V., Krupanandan, R., Nambi, P. S., & Ramachandran, B. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.640857 · Cited by 14
Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures
Roper, S., Wingler, M. J. B., & Cretella, D. A. (2023) · Pharmacy · doi:10.3390/pharmacy11030104 · Cited by 12
“One concern associated with de-escalation is that some evidence suggests that deescalation may be associated with an increased duration of therapy [24].”
Backgroundzhao, K., Zhang, Z.-D., liang, Y., Wang, Y., & Cai, Y. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08491-7 · Cited by 13
“However, the impact of this strategy on patient outcomes remains controversial, despite the results of a multicenter non-blinded randomized noninferiority trial suggesting no effect on mortality [14, 16].”
BackgroundResultYoo, J. S., Park, J. Y., Chun, H.-J., Kim, Y. R., Kim, E. J., Choi, Y. H., Ha, K. H., & Heo, J. Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-41710-4 · Cited by 13
“Previous studies showed inconsistent findings for antibiotic de-escalation in critically ill patients 25,26 .”
ResultAnderson, B., McClellan, W. S., & Long, C. R. (2021) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2021.03.001 · Cited by 10
Fernandez, J. A., del Pozo, J. L., Leiva, J., Fernández-Alonso, M., Aquerreta, I., Aldaz, A., Matteo, A. B.-D., & Yuste, J. R. (2022) · Antibiotics · doi:10.3390/antibiotics11030330 · Cited by 12
“Although there are studies where antibiotic adjustment has been associated with worse outcomes, such as increased length of stay [20], an antibiotic adjustment (mainly deescalation) is endorsed by many societies, such as the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology…”
BackgroundUmpleby, H., Dushianthan, A., Catton, T., & Saeed, K. B. A. (2022) · Journal of Emergency and Critical Care Medicine · doi:10.21037/jeccm-22-6 · Cited by 17
Infection management in patients with sepsis and septic shock in resource-limited settings
Thwaites, L., Lundeg, G., & Dondorp, A. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4547-5 · Cited by 12
Schnell, D., Montlahuc, C., Bruneel, F., Resche‐Rigon, M., Kouatchet, A., Zahar, J., Darmon, M., Pène, F., Lemiale, V., Rabbat, A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05554-9 · Cited by 10
Safety of antimicrobial de-escalation for culture-negative severe pneumonia
Soo, K. B., Choi, S., Koh, Y., Jin-Won, H., Sang-Bum, H., & Chae-Man, L. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.06.026 · Cited by 10
“In that study's subgroup analysis of 56 patients with pneumonia, the ICU stays and superinfection episodes did not differ between the ADE and non-ADE groups [20].”
BackgroundMethodResultInfluentialTrifi, A., Abdellatif, S., Abdennebi, C., Daly, F., Nasri, R., Touil, Y., & Lakhal, S. B. (2018) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-018-0292-7 · Cited by 10
“[27] showed that de-escalation was safe and associated with lower antibiotic use and shorter antibiotic duration; and theoretically a beneficial effect on the MDR emergence [27, 28].”
BackgroundAldardeer, N. F., Qushmaq, I. A., Alshehail, B. M., Ismail, N., Alhameed, A. F., Damfu, N., Musawa, M. A., Nadhreen, R., Kalkatawi, B. S., Saber, B., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00124-1 · Cited by 17
“Nevertheless, the trial was not powered for this outcome [28].”
BackgroundLópez-Cortés, L. E., Rosso-Fernández, C. M., Núñez‐Núñez, M., Lavín-Alconero, L., Bravo-Ferrer, J. M., Barriga, Á., Delgado-Valverde, M., Lupión, C., Retamar, P., & Rodríguez‐Baño, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015439 · Cited by 8
Impaired Granuloma Formation in Sepsis: Impact of Monocytopenia
Alingrin, J., Coiffard, B., Textoris, J., Bélénotti, P., Daumas, A., Léone, M., & Mège, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158528 · Cited by 10
Self-citationAntimicrobial de-escalation is part of appropriate antibiotic usage in ICU
Timsit, J., Lipman, J., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05951-5 · Cited by 9
Pneumonies associées aux soins de réanimation* RFE commune SFAR–SRLF
Léone, M., Bouadma, L., Bouhemad, B., Brissaud, O., Dauger, S., Gibot, S., Hraiech, S., Jung, B., Kipnis, É., Launey, Y., et al. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0106 · Cited by 8
Rashidzada, Z., Cairns, K. A., Peel, T. N., Jenney, A. W. J., Doyle, J., Dooley, M. J., & Cheng, A. C. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab097 · Cited by 7
Pichon, M., Cremniter, J., Burucoa, C., the COVAP Study group, Abdallah, S., Alauzet, C., Alix, T., Allouche, K., Amara, M., Anglade, F., et al. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00603-0 · Cited by 7
“Optimization of antibiotic therapy in suspected VAP, which is crucial for proper clinical management of the disease, depends on the risk factor for the carriage of multiresistant bacteria (MDR), and cannot be limited to an unwarranted combination of antibiotics [8, 11].”
BackgroundInfection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings
Thwaites, L., Lundeg, G., Dondorp, A. M., Adhikari, N. K. J., Nakibuuka, J., Jawa, R. S., Mer, M., Murthy, S., Schultz, M. J., Thien, B. N., et al. (2019) · Springer eBooks · doi:10.1007/978-3-030-03143-5_8 · Cited by 12
Fu, R., Chen, T., Song, J., Wang, G., Li, L., Ruan, E., Liu, H., Wang, Y., Wang, H., Xing, L., et al. (2017) · Medicine · doi:10.1097/md.0000000000005905 · Cited by 7
Umemura, Y., Yamakawa, K., Tanaka, Y., Yoshimura, J., Ogura, H., & Fujimi, S. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005932 · Cited by 6
Saito, N., Tsuchiya, J., Itoga, M., Okamura, Y., Tsuyama, H., Kimura, M., Inoue, F., Kimura, T., Ozaki, H., Tono, Y., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s445917 · Cited by 7
“25,35 However, the International Guidelines for Management of Sepsis and Septic Shock 2021 suggested that daily assessment for antimicrobial de-escalation over using fixed durations of therapy without daily reassessment for de-escalation was only a weak recommendation (very low quality of evidence).”
BackgroundMakina, A., Poulakou, G., Sympardi, S., Souli, M., Liakopoulou, E., Matthaiou, D. K., Karaiskou, A., Arvaniti, A., Charalabaki, N., Antoniadou, A., et al. (2019) · Infectious Diseases and Clinical Microbiology · doi:10.5152/idcm.2019.19003 · Cited by 6
Lakbar, I., Delamarre, L., Curtel, F., Duclos, G., Bézulier, K., Gragueb-Chatti, I., Martín‐Loeches, I., Forel, J.-M., & Léone, M. (2022) · Antibiotics · doi:10.3390/antibiotics11111517 · Cited by 6
“A prolonged treatment duration was associated with ADE in a randomized controlled trial that compared ADE and continuation of “pivotal” empirical antibiotics [21], as well as in patients with neutropenia [22].”
BackgroundResultSelf-citationAntibiotic de-escalation: observational causal inference and culture dependence
Kitsios, G. D., Morris, A. M., & McVerry, B. J. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4443-z · Cited by 6
“Targeted de-escalation should thus be studied in those cases with identification of a causal pathogen, as performed in a recent controlled trial that randomized patients to de-escalation or continuation strategies, only after an antibiogram was available [3].”
BackgroundESTRATEGIAS PARA EL USO DE ANTIBIÓTICOS EN PACIENTES CRÍTICOS
Arancibia, J. M. (2019) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2019.03.001 · Cited by 18
Safety considerations of current drug treatment strategies for nosocomial pneumonia
Ceccato, A., Giannatale, P. D., Nogas, S., & Torres, A. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1857362 · Cited by 7
Clinical and biological advances of critical complications in acute myeloid leukemia
Costa, A. N., Scalzulli, E., Carmosino, I., Ielo, C., Bisegna, M. L., Martelli, M., & Breccia, M. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2425051 · Cited by 5
“De-escalation strategies, well-established in icU for severe sepsis management, are preferred for high-risk patients facing multi-drug-resistant pathogens, although with limited icU-specific data for AMl patients [75].”
„Antibiotic Stewardship“: Maßnahmen zur Optimierung der Verordnung von Antiinfektiva
Lanckohr, C., & Bracht, H. (2018) · Der Anaesthesist · doi:10.1007/s00101-017-0398-x · Cited by 5
“Ebenso scheint die Deeskalation nach Resistogramm bei Intensivpatienten in vielen Situationen möglich, ohne dass Komplikationen befürchtet werden müssen [13, 23, 30].”
Duclos, G., Pastène, B., Depeyre, F., Meresse, Z., Cassir, N., Martín‐Loeches, I., Einav, S., Zieleskiewicz, L., & Léone, M. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.09.56 · Cited by 5
“Table 3 Details of postoperative colonization and microbiological findings Analyzed variable Group 1 (n=10) Group 2 (n=3) Group 3 (n=3) Group 4 (n=21) Site of colonization, n [%] Lung 0 1 [33] 0 1 [5] Urinary tract 0 1 [33] 0 3 [14] Digestive tract 0 0 0 0 Bacteremia 0 0 0 0 Soft tissues 0 0 0 0 SSI 0 0 1 [33] 0 Total…”
A narrative review on antimicrobial therapy in septic shock: updates and controversies
Ling, L., Joynt, G. M., & Lipman, J. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000954 · Cited by 5
“In contrast, clinical evidence demonstrating that de-escalation reduces emergence of multidrug- resistant organisms is less consistent [62,69,71,72].”
ResultPedroso, J. V. D. M., Motter, F. R., Koba, S. T., de Camargo, M. C., de Toledo, M. I., Fiol, F. D. S. D., Silva, M. T., & Lopes, L. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.576849 · Cited by 5
“, 2016) and randomized clinical trial (Leone et al., 2014) found that the de-escalation did not affect the emergence of multidrug-resistant (MDR) pathogens.”
Backgroundde Lorenzi-Tognon, M., & Schrenzel, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-60041-6 · Cited by 6
Pereira, L. B., Zanetti, M. O. B., Rodrigues, J. P. V., & Pereira, L. R. L. (2022) · Research Society and Development · doi:10.33448/rsd-v11i2.25573 · Cited by 5
Kapoor, G. T., & Saigal, S. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3476-4 · Cited by 5
“Thirty-nine per cent of patients in the de-escalation group had undergone some form of surgery as compared to 29 % in the continuation group [3].”
ResultRapti, V., Poulakou, G., Mousouli, A., Kakasis, A., Pagoni, S., Pechlivanidou, E., Masgala, A., Sympardi, S., Apostolopoulos, V., Giannopoulos, C., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13090812 · Cited by 6
“The increased occurrence of superinfections, observed both in our study and the RCT conducted by Leone et al., should be interpreted with caution, and the small number of patients experiencing a new infection should be taken into account [40].”
BackgroundResultInfluentialPark, I., Kim, D., Lee, J. H., Park, S. J., Jeong, H., Baek, S., Kim, S., Kim, S., Hwang, J. E., Kwon, H., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00864-22 · Cited by 4
Ibrahim, N. A., Makmor‐Bakry, M., Ishak, S., & Shah, N. M. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v12i1.29489 · Cited by 4
Sepsis Management in Resource-Limited Settings
Arslantaş, M. K., & Özdemir, H. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004536 · Cited by 4
Antimicrobial therapy in patients with septic shock
Pastène, B., Duclos, G., Martin, C., & Léone, M. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.03.006 · Cited by 7
Self-citationAntimicrobial Stewardship in ICU
Schouten, J. A., & Waele, J. J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810477-4.00016-7 · Cited by 6
Farsani, A., Thandi, P., & Htway, Z. (2025) · Cureus · doi:10.7759/cureus.90728 · Cited by 6
“For example, Leone et al. demonstrated noninferiority in mortality when de-escalation was employed in severe sepsis, while Joung et al. showed no adverse impact on outcomes for ICU-acquired pneumonia [17,18].”
Daneman, N., Johnstone, J., Lee, T. C., MacFadden, D. R., McDonald, E. G., Morpeth, S. C., Ong, S. W. X., Paterson, D. L., Pinto, R. L., Rishu, A. H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101588 · Cited by 3
Antibiotic de-escalation: finally, some action and not only words
Tabah, A., Bus, L. D., & Léone, M. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00749-1 · Cited by 3
Kim, Y. C., Kim, J. H., Ahn, J. Y., Jeong, S. J., Ku, N. S., Choi, J. Y., Yeom, J., Park, Y. S., Song, Y. G., & Kim, H. Y. (2020) · Antibiotics · doi:10.3390/antibiotics9050250 · Cited by 3
“A study reported that DE therapy did not increase mortality risk in patients with severe sepsis or septic shock [4].”
BackgroundYarrington, M. E., Moehring, R. W., David, M. Z., Hamilton, K. W., Klompas, M., Rhee, C., Hsueh, K., Ashley, E. D., Sinkowitz‐Cochran, R. L., Ryan, M., et al. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.205 · Cited by 4
Antimicrobial Agents in Agriculture and Their Implications in Antimicrobial Resistance
Singh, S., & Goyal, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84126-3_3 · Cited by 5
Kaylor, D. M., Caminiti, N., Harbrecht, B. G., McPheeters, C. M., & Scherrer, L. A. (2022) · Surgical Infections · doi:10.1089/sur.2022.126 · Cited by 3
Alviset, S., Rodari, S., Poupet, H., Mizrahi, A., Gastli, N., Philippart, F., Charpentier, J., Pilmis, B., & Kernéis, S. (2023) · Infectious Diseases Now · doi:10.1016/j.idnow.2023.104773 · Cited by 4
Escrihuela-Vidal, F., Palacios-Baena, Z. R., Agirre, J. G., Pérez-Rodríguez, M. T., Iglesias, J. M. R., Pedragosa, J. C., Gómez, L. S., Boix-Palop, L., Carrasco, A. B., Natera-Kindelán, C., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107317 · Cited by 3
Léone, M., Bechis, C., & Baumstarck, K. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3479-1 · Cited by 3
Self-citationFocus on adequate antimicrobial treatment and de-escalation in the ICU
Benoît, D., Doig, G. S., & Timsit, J. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4566-2 · Cited by 3
Rapid identification of antimicrobial resistance patterns allows a faster antibiotic adequacy
Ceccato, A., Ranzani, O., & Torres, A. (2017) · Critical Care · doi:10.1186/s13054-017-1797-8 · Cited by 3
“Furthermore, if the initial antibiotic treatment is subsequently modified in the light of the culture results, the patient’s outcome does not seem to be affected [5].”
BackgroundAntibiotic de-escalation practices in the intensive care unit: a multicenter observational study
Patanwala, A. E., Abu Sardaneh, A., Alffenaar, J.-W. C., Choo, C. L., Dey, A. L., Duffy, E. J., Green, S. E., Hills, T. E., Howle, L. M., Joseph, J. A., et al. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280241271223 · Cited by 2
Antibiotic stewardship: do not rely on de-escalation alone
Bus, L. D., & Depuydt, P. O. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4457-6 · Cited by 2
File, T. M., Jump, R., & Goff, D. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.002 · Cited by 3
Khan, M. R., Saleem, Z., Batool, N., Babar, M., & Shabbir, A. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221077929 · Cited by 2
Ouranos, K., & Mylonakis, E. E. (2024) · Annals of Internal Medicine · doi:10.7326/j24-0030 · Cited by 2
Blot, M., Pivot, D., Bourredjem, A., Salmon‐Rousseau, A., de Curraize, C., Croisier, D., Chavanet, P., Binquet, C., & Piroth, L. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.027 · Cited by 2
Antimicrobial Stewardship Metrics that Matter
Wagner, J. L., Carreno, J. J., Kenney, R. M., Kilgore, P. E., & Davis, S. L. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000832 · Cited by 2
“883 Skin and soft tissue/wound 66 (15) 44 (16) 22 (13) 0.”
InfluentialImpact of Extended and Restricted Antibiotic Deescalation on Mortality
Teh, H. L., Abdullah, S., Ghazali, A. K., Khan, R. A., Ramadas, A., & Leong, C. L. (2021) · Antibiotics · doi:10.3390/antibiotics11010022 · Cited by 2
“Two other studies conducted in ICU settings also generated similar results [8,26].”
ResultOptimization of antibiotic use in the intensive care unit: how we do it
Moniz, P., Fustiga, J., Herculano, M. M., & Póvoa, P. M. S. R. (2024) · Critical Care Science · doi:10.62675/2965-2774.20240017-en · Cited by 2
“(14)”
BackgroundMakino, J., Honda, M., Sato, F., Morikawa, Y., Goto, T., Asuke, J., & Okada, K. (2026) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2026.102946 · Cited by 1
Nikolai, L. A., Hornuß, D., Gladstone, B. P., Walker, S. V., Vehreschild, J. J., Schmauder, K., Eisenbeis, S., Mischnik, A., Kramme, E., Geffers, C., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107908 · Cited by 1
Measurement in Antibiotic Stewardship
Ashley, E. S. D., & Stenehjem, E. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316694411.008 · Cited by 1
(2017) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12182
Singh, A., Ghosh, S., & Lyall, A. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24505 · Cited by 2
“Intensive Care Med 2020;46(7): 1404–1417.”
Pneumonie associée à la ventilation mécanique
Pisanu, G., Fartoukh, M. S., & Garnier, M. (2018) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2018.01.005 · Cited by 2
Optimal antimicrobial therapy and antimicrobial stewardship in sepsis and septic shock
Seok, H., & Park, D. W. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.12.638 · Cited by 1
Réévaluation clinico-biologique de l’antibiothérapie probabiliste en réanimation des brules
Moutaouakkil, Y., Siah, S., Bennana, A., Tadlaoui, Y., Makram, S., Cherrah, Y., Bousliman, Y., & Lamsaouri, J. (2018) · PubMed Central · Cited by 1
Abutheraa, N., Grant, J., & Mullen, A. B. (2020) · Pharmacy · doi:10.3390/pharmacy8040211 · Cited by 2
“35, respectively [28], which emphasised the safety of the de-escalation protocol and encourages healthcare professionals to de-escalate when possible to slow the development of antimicrobial resistance.”
BackgroundHow to use new antibiotics in the therapy of ventilator-associated pneumonia
Miwa, T., Lizza, B. D., Burnham, J. P., Honda, H., & Kollef, M. H. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000811 · Cited by 1
“Although the safety of de-escalation in critically ill patients, such as those with VAP, was unclear for a long time [94], a recent, multicentre, nonblinded RCT showed noninferiority of de-escalation in comparison with continued empiric therapy in terms of mortality [95].”
ResultNosokomiale Pneumonien und beatmungsassoziierte Krankenhauserreger: Teil 2: Therapie
Flick, H., Hermann, M., Urban, M., & Meilinger, M. (2022) · Anästhesie Nachrichten · doi:10.1007/s44179-022-00108-9 · Cited by 1
“– Nach Erregeridentifikation und Stabilisierung der klinischen Situation (Therapieansprechen) sollte die Therapie frühzeitig deeskaliert oder fokussiert werden [15, 16].”
BackgroundGutiérrez-Pizarraya, A., Léone, M., Garnacho‐Montero, J., Claude, M., & Martín‐Loeches, I. (2016) · Heart & Lung · doi:10.1016/j.hrtlng.2016.10.001 · Cited by 1
Antibiotic Stewardship in Community-acquired Pneumonia
van Heijl, I. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/332 · Cited by 2
Antibioticoterapia probabilistica in rianimazione
Malaquin, S., Mahjoub, Y., Montravers, P., & Dupont, H. (2017) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(17)85872-2
Pneumopatie nosocomiali acquisite sotto ventilazione meccanica
Guerin, R., & Constantin, J.-M. (2016) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(15)76135-9
Self-citation
Metadata
- Authors
- Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., Allaouchiche, B., Bézulier, K., Antonini, F., Textoris, J., Martin, C., & For the AZUREA Network Investigators
- Affiliations
- Hôpital Nord (FR)
- Aix-Marseille Université (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Hôpital de la Conception (FR)
- Inserm (FR)
- Hospices Civils de Lyon (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Centre National de la Recherche Scientifique (FR)
- Hôpital de la Timone (FR)
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2014-08-05
- Volume
- 40
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2053430308
- Cited by
- 243
- References
- 32
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 17 · 2021: 18 · 2020: 28 · 2019: 27 · 2018: 18 · 2017: 22 · 2016: 32 · 2015: 14 · 2014: 5
- FWCI
- 18.32
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-10-07)
- Open access
- green
- hal.umontpellier.fr
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- severe sepsis, antibiotic de-escalation, empirical antimicrobial therapy, ICU length of stay, superinfection, antibiotic duration, mortality, organ failure
- MeSH terms
- Aged, Anti-Bacterial Agents, Female, France, Humans, Intensive Care Units, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Multivariate Analysis, Linear Models, Proportional Hazards Models, Sepsis, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.